HeartBeam, Inc. (BEAT)
- Previous Close
2.0400 - Open
2.0100 - Bid 1.9500 x 100
- Ask 2.1200 x 100
- Day's Range
2.0000 - 2.0650 - 52 Week Range
1.0600 - 3.7400 - Volume
13,853 - Avg. Volume
127,038 - Market Cap (intraday)
53.974M - Beta (5Y Monthly) -1.22
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7200 - Earnings Date May 11, 2024 - May 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.33
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
www.heartbeam.com15
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BEAT
Performance Overview: BEAT
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BEAT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BEAT
Valuation Measures
Market Cap
53.97M
Enterprise Value
37.79M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.39
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-2.47
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-90.42%
Return on Equity (ttm)
-159.89%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-14.64M
Diluted EPS (ttm)
-0.7200
Balance Sheet and Cash Flow
Total Cash (mrq)
16.19M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-7.28M